SCARA5 and non-small cell lung carcinoma: However, CM-272 reduced levels of the transcriptional repression mark H3K9me2 bound to the promoter regions of SCARA5 and AOX1, which suggests that, at least in NSCLC cancer cells, this may constitute a main mechanism of activity.